These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25273126)

  • 1. Circulating Inflammatory Cytokines Are Associated With the Risk of Barrett's Esophagus in Western Persons.
    Nam SY
    J Neurogastroenterol Motil; 2014 Oct; 20(4):558-9. PubMed ID: 25273126
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus.
    Schneider JL; Zhao WK; Corley DA
    Dig Dis Sci; 2015 Feb; 60(2):436-43. PubMed ID: 25213077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Th-2 cytokines in the development of Barrett's esophagus in rats.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Wei M; Wanibuchi H; Arakawa T
    J Gastroenterol; 2011 Jul; 46(7):883-93. PubMed ID: 21590343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endoscopic diagnosis of Barrett's esophagus].
    Hoshihara Y; Kogure T; Yamamoto T; Hashimoto M; Hoteya O
    Nihon Rinsho; 2005 Aug; 63(8):1394-8. PubMed ID: 16101228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for Barrett's esophagus.
    Rubenstein JH
    Curr Opin Gastroenterol; 2014 Jul; 30(4):408-14. PubMed ID: 24859804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
    O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
    BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Barrett's esophagus: its diagnosis and management in Japan].
    Amano Y; Azumi T
    Nihon Rinsho; 2015 Jul; 73(7):1129-35. PubMed ID: 26165069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.
    Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA
    Am J Gastroenterol; 2016 Nov; 111(11):1528-1535. PubMed ID: 27575711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origins of Metaplasia in Barrett's Esophagus: Is this an Esophageal Stem or Progenitor Cell Disease?
    Zhang W; Wang DH
    Dig Dis Sci; 2018 Aug; 63(8):2005-2012. PubMed ID: 29675663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus.
    Kubo A; Levin TR; Block G; Rumore GJ; Quesenberry CP; Buffler P; Corley DA
    Gastroenterology; 2009 Mar; 136(3):806-15. PubMed ID: 19111726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abdominal obesity and body mass index as risk factors for Barrett's esophagus.
    Corley DA; Kubo A; Levin TR; Block G; Habel L; Zhao W; Leighton P; Quesenberry C; Rumore GJ; Buffler PA
    Gastroenterology; 2007 Jul; 133(1):34-41; quiz 311. PubMed ID: 17631128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progression and extending speed of Barrett's esophagus].
    Kawano T; Ogiya K; Nakamura M
    Nihon Rinsho; 2005 Aug; 63(8):1350-5. PubMed ID: 16101220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
    Wang F; Lv ZS; Fu YK
    Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study.
    Buttar NS; Wang KK; Anderson MA; Dierkhising RA; Pacifico RJ; Krishnadath KK; Lutzke LS
    J Natl Cancer Inst; 2002 Mar; 94(6):422-9. PubMed ID: 11904314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus and medications that relax the lower esophageal sphincter.
    Corley DA; Levin TR; Habel LA; Buffler PA
    Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's esophagus: prevalence in symptomatic relatives.
    Romero Y; Cameron AJ; Schaid DJ; McDonnell SK; Burgart LJ; Hardtke CL; Murray JA; Locke GR
    Am J Gastroenterol; 2002 May; 97(5):1127-32. PubMed ID: 12017151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus.
    Kubo A; Block G; Quesenberry CP; Buffler P; Corley DA
    Nutr Cancer; 2009; 61(5):607-16. PubMed ID: 19838934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.